50 Participants Needed

Vitamin D Supplementation for Premature Infants

SJ
JB
Overseen ByJordan Burdine, PharmD, MBA, BCPPS
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: The University of Texas Health Science Center, Houston
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

The objective of the study is to compare supplementation with vitamin D at 800 IU/day to usual care for the first 28 days after birth with respect to 25 (OH) vitamin D levels and indicators of likely or plausible effects of vitamin D supplementation on the function or structure of the lung, bones, immune system, and brain in extremely premature (EP) infants who are \<28 weeks gestational age (GA) or \<1000 grams of birth weight (BW). The study results will be analyzed as intention to treat Bayesian analyses (Frequentist analyses will also be performed).

Will I have to stop taking my current medications?

The trial information does not specify whether participants must stop taking their current medications.

Is vitamin D supplementation safe for premature infants?

Vitamin D supplementation in premature infants is generally safe, but it should be monitored to avoid overdose. Some studies have shown that high doses can lead to potentially toxic levels, so careful monitoring is important to ensure safety.12345

How does the drug Vitamin D3 supplementation for premature infants differ from other treatments?

The 800 IU/day vitamin D3 supplementation for premature infants is unique because it provides a higher dose than typically recommended, aiming to better support bone health and overall development in the first 28 days after birth, while the standard dose often ranges from 400 to 960 IU/day.678910

What data supports the effectiveness of the drug 800 IU/day vitamin D supplementation for premature infants?

Research shows that early supplementation with 800 IU of vitamin D is effective and safe for very low birth weight infants, helping to improve their vitamin D levels. Another study found that even lower doses of vitamin D (500 IU) increased vitamin D levels in premature infants, suggesting that 800 IU could be even more effective.13111213

Who Is on the Research Team?

SJ

Sunil Jain, MD

Principal Investigator

The University of Texas Medical Branch

Are You a Good Fit for This Trial?

This trial is for very premature infants born at less than 28 weeks or weighing under 1000 grams. It's not for babies with conditions affecting vitamin D absorption, like cystic fibrosis, those too sick where intensive care isn't justified, with congenital infections, over 32 weeks gestation, or with major birth defects.

Inclusion Criteria

My condition is congenital.
Informed written consent in an Institutional Review Board (IRB)-approved manner
My baby was born before 28 weeks or weighed less than 1000 grams.

Exclusion Criteria

Any major congenital anomaly
Any known congenital nonbacterial infection
Such severe illness or immaturity that the attending neonatologist judges intensive care to be unjustified.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Infants receive either vitamin D supplementation or placebo for the first 28 days after birth

4 weeks
Daily administration

Follow-up

Participants are monitored for growth, neurodevelopment, and respiratory outcomes

2 years

Extended Follow-up

Monitoring of respiratory support and neurodevelopmental outcomes

22 to 26 months corrected age

What Are the Treatments Tested in This Trial?

Interventions

  • 800 IU/day vitamin D supplementation with feedings in the first 28 days after birth
  • Placebo
  • Usual Care
Trial Overview The study tests if giving a high dose of vitamin D (800 IU/day) to extremely premature babies helps their bones, lungs, immune system and brain compared to usual care. Babies are randomly given either the vitamin D supplement or no extra vitamins in their first month.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Usual care plus vitamin D supplementationExperimental Treatment2 Interventions
Group II: Usual care plus placeboActive Control2 Interventions

800 IU/day vitamin D supplementation with feedings in the first 28 days after birth is already approved in European Union, United States, Canada for the following indications:

🇪🇺
Approved in European Union as Cholecalciferol for:
🇺🇸
Approved in United States as Vitamin D3 for:
🇨🇦
Approved in Canada as Cholecalciferol for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

The University of Texas Health Science Center, Houston

Lead Sponsor

Trials
974
Recruited
361,000+

Published Research Related to This Trial

In a study of 66 very low birth weight (VLBW) infants, early supplementation with 800 IU of vitamin D starting at 2 weeks of age was found to be safe and effective, achieving an 88% probability of vitamin D sufficiency by 36 weeks for those with initial levels ≥10 ng/mL.
For infants with lower initial vitamin D levels (<10 ng/mL), the supplementation still showed promise, with a 65% probability of achieving sufficiency, indicating that vitamin D intake may significantly improve vitamin D status in vulnerable populations like VLBW infants.
Efficacy and safety of early supplementation with 800 IU of vitamin D in very preterm infants followed by underlying levels of vitamin D at birth.Cho, SY., Park, HK., Lee, HJ.[2022]
In a study of 25 healthy premature infants, daily supplementation of 500 IU of vitamin D2 significantly increased their plasma 25-hydroxyvitamin D levels from 30.6 nmol/l at birth to 65.3 nmol/l after 37 days, indicating effective absorption and metabolism of vitamin D2.
The increase in vitamin D levels was primarily due to the D2 fraction, while levels of vitamin D3 remained unchanged, suggesting that vitamin D2 supplementation is effective for rapidly achieving adequate vitamin D status in premature infants.
Vitamin D nutritional status of premature infants supplemented with 500 IU vitamin D2 per day.Markestad, T., Aksnes, L., Finne, PH., et al.[2019]
In a study of 111 preterm babies, 12.6% were found to be vitamin D insufficient at birth, but this number rose dramatically to 52.2% at 6 weeks despite daily supplementation of 400 IU of vitamin D.
The findings suggest that the current recommended daily dose of 400 IU is insufficient to prevent vitamin D insufficiency in preterm infants, indicating a need for further research into higher supplementation doses.
Vitamin D status and adequacy of standard supplementation in preterm neonates from South India.Tergestina, M., Jose, A., Sridhar, S., et al.[2018]

Citations

Efficacy and safety of early supplementation with 800 IU of vitamin D in very preterm infants followed by underlying levels of vitamin D at birth. [2022]
Vitamin D nutritional status of premature infants supplemented with 500 IU vitamin D2 per day. [2019]
Vitamin D status and adequacy of standard supplementation in preterm neonates from South India. [2018]
A randomized double-blind controlled trial comparing two regimens of vitamin D supplementation in preterm neonates. [2022]
Vitamin D status in very low birth weight infants and response to vitamin D intake during their NICU stays: a prospective cohort study. [2022]
Monitored Supplementation of Vitamin D in Preterm Infants: A Randomized Controlled Trial. [2021]
Vitamin D in Preterm and Full-Term Infants. [2021]
Vitamin D and mineral metabolism in the very low birth weight infant receiving 400 IU of vitamin D. [2019]
Randomized trial of two doses of vitamin D3 in preterm infants [2018]
10.United Statespubmed.ncbi.nlm.nih.gov
Serum 25 Hydroxy Vitamin D Levels in Very Low Birth Weight Infants Receiving Oral Vitamin D Supplementation. [2019]
11.United Statespubmed.ncbi.nlm.nih.gov
Vitamin D Intake in Very Low Birth Weight Infants in Neonatal Intensive Care Unit. [2018]
Randomised controlled trial of vitamin D supplementation on bone density and biochemical indices in preterm infants. [2019]
Plasma 1.25-dihydroxyvitamin D concentrations in preterm infants. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security